1 / 6

Rapid Influenza Diagnostic Tests (RIDT) Market Size 2030

The Global Rapid Influenza Diagnostic Tests (RIDT) market study focuses major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. It provides information on trends and developments, and focuses on markets and materials, capacities and technologies, and on the changing structure.

energy010
Download Presentation

Rapid Influenza Diagnostic Tests (RIDT) Market Size 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Rapid Influenza Diagnostic Tests (RIDT) Market by Manufacturers, Regions, Type and Application Forecast to 2030 © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  2. Market Scenario of Rapid Influenza Diagnostic Tests (RIDT) Market • Global Market Insights add New Global Rapid Influenza Diagnostic Tests (RIDT) Market report provides in-depth information about market overview, top vendors, Key market highlights, product types, market drivers, challenges, trends, Rapid Influenza Diagnostic Tests (RIDT) industry landscape, size and forecast, five forces analysis, Key leading countries/Region. • The rapid influenza diagnostic tests (RIDT) market is expected to grow significantly by 2030 owing to increasing prevalence of influenza. • In addition, surging necessity for early diagnosis, along with rising popularity of rapid testing, is set to further boost market growth through the forecast period. • Notably, lack of skilled professionals and stringent lockdown regulations imposed during the COVID-19 outbreak posed a threat to market growth However, with the burgeoning number of cases and high risk of exposure to COVID-19 in hospital settings, at-home testing gained massive popularity. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  3. Continue:- • Thus, rising consumer interest in at-home testing kits, coupled with soaring demand for telemedicine for influenza infection diagnosis, has positively impacted the product landscape of the rapid influenza diagnostic tests (RIDT) market. • Furthermore, major players in the industry have been focusing on research and development activities to introduce technologically advanced rapid influenza tests. In addition, strategic partnerships and acquisitions have also aided in business expansion. • For instance, in October 2020, Quidel Corporation, a leading manufacturer of diagnostic healthcare products, received EUA (Emergency Use Authorization) from the U.S. FDA (Food and Drug Administration) for marketing its Sofia 2 Flu + SARS Antigen FIA, a rapid point-of-care test used in conjunction with Sofia 2 Fluorescent Immunoassay Analyzer to differentiate nucleocapsid protein antigen from SARS-CoV-2 and influenza A and B via direct nasal (NS) and nasopharyngeal (NP) swab samples in potential COVID-19 patients. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  4. 360° Industry Analysis • To cite another instance, in March 2021, Abbott, a multinational medical and healthcare devices company, introduced its Alinity m Resp-4-Plex assay that detects COVID-19, influenza A, influenza B, and RSV using only one swab. • The innovation, which has received U.S. FDA Emergency Use Authorization, aims to reduce discomfort, and give an efficient four-in-one assay for quick diagnosis. • In another instance, in January 2021, Thermo Fisher Scientific, a prominent supplier in the rapid influenza diagnostic tests (RIDT) market, announced its plans to takeover molecular diagnostic expert Mesa Biotech. • Mesa provides gold-standard nucleic acid PCR (polymerase chain reaction) amplification to point-of-care diagnostics for COVID-19, RSV, Influenza A and B, and Strep A. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  5. Competitive Analysis: • Quidel Corporation • Abbott • DiaSorinSpA • Thermo Fischer Scientific Inc. • Becton • Dickinson and Company • Meridian Bioscience Inc. • Browse Complete Summary of this report @ https://www.gminsights.com/industry-analysis/rapid-influenza-diagnostic-tests-ridt-market © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  6. Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

More Related